Efficacy of Recombinant FSH/GnRH Antagonist Protocol With and Without LH Adjunct for Egg Bank Donation

PHASE4CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

February 12, 2017

Study Completion Date

March 8, 2017

Conditions
Egg Donation
Interventions
DRUG

Follistim

Follicle stimulating hormone promotes recruitment of follicles for ovulation.

DRUG

Ganirelix

GnRH antagonist preventing a problematic risk of premature LH surge during ovulation induction therapy.

DRUG

Menotropins

Combination of follicle stimulating hormone and Luteinizing hormone activity promotes recruitment of follicles for ovulation. Absence or presence of this medication is the difference being tested between the two arms of the study.

DRUG

Leuprolide

Promotes endogenous LH surge signaling oocyte maturation followed by ovulation. This controls timing for oocyte collection.

PROCEDURE

Transvaginal ultrasound guided needle aspiration of oocytes

Trial Locations (1)

48304-5130

Michigan Reproductive Medicine, Bloomfield Hills

All Listed Sponsors
lead

Michigan Reproductive Medicine

OTHER

NCT02069808 - Efficacy of Recombinant FSH/GnRH Antagonist Protocol With and Without LH Adjunct for Egg Bank Donation | Biotech Hunter | Biotech Hunter